Differential Sensitivity of Human Hepatocellular Carcinoma Xenografts to an IGF-II Neutralizing Antibody May Involve Activated STAT3

Hepatocellular carcinoma (HCC) is highly refractory to current therapeutics used in the clinic. DX-2647, a recombinant human antibody, potently neutralizes the action of insulin-like growth factor-II (IGF-II), a ligand for three cell-surface receptors (IGF-IR, insulin receptor A and B isoforms, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Greenall, Sameer A., Donoghue, Jacqueline, Johns, Terrance G., Adams, Timothy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2018
Materias:
Original article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020079/
https://www.ncbi.nlm.nih.gov/pubmed/29933129
http://dx.doi.org/10.1016/j.tranon.2018.05.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6020079/
https://www.ncbi.nlm.nih.gov/pubmed/29933129
http://dx.doi.org/10.1016/j.tranon.2018.05.011

Ejemplares similares